Bruker Corp (BRKRP) company profile
Close on Nov 12, 2026Market cap $9.36BP/E –Yield –
About Bruker
Laboratory Analytical Instruments, SIC 3826
Bruker develops, manufactures, and distributes high-performance scientific instruments alongside analytical and diagnostic solutions. Its technology platforms span magnetic resonance, mass spectrometry, chromatography, X-ray systems, microscopy, metrology, and molecular spectroscopy. The company organizes its business into four reportable segments: BSI BioSpin, BSI CALID, BSI NANO, and BEST. These offerings serve customers across life science and materials research, biopharmaceuticals, clinical microbiology, molecular diagnostics, nanotechnology, and industrial applied markets, including academic institutions, government bodies, healthcare providers, and commercial enterprises.
The company maintains major manufacturing and technical facilities across North America and Europe, complemented by sales offices globally. Bruker is headquartered in Billerica, Massachusetts.
Summary of the business section of Bruker's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Bruker Corp
- Founded
- 1960
- Headquarters
- Billerica, MA
- Address
- 40 Manning Rd 01821
- Phone
- (978) 663-3660
- Website
- www.bruker.com
- Employees
- 11,085, Dec 31, 2025
- Industry
- Laboratory Analytical Instruments
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Boston, Massachusetts
Stock & identifiers
- Ticker
- BRKRP
- Other tickers
- BRKR
- Exchange
- Nasdaq
- IPO date
- Aug 4, 2000
- Shares outstanding
- 155M, Aug 3, 2026
- Public float
- $4.25B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1109354
- CUSIP
- 116794108
- ISIN
- US1167941087
- LEI
- LEBZ6VLQ6I8XB1NHVY15
- EIN
- 04-3110160
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Frank H. Laukien | PRESIDENT & CEO, Director | 40,106,023 |
| Mark Munch | EXEC VP&PRES BRUKER NANO INC. | 134,806 |
| Juergen Srega | PRESIDENT CALID | 174,625 |
| Burkhard Prause | PRES. & CEO, BRUKER BEST | 28,461 |
| Gerald N. Herman | EXECUTIVE VICE PRESIDENT, CFO | 111,354 |
| Wolfgang Pusch | President BMID Group | 9,801 |
| Thomas Bures | Chief Accounting Officer | 7,233 |
| Falko Busse | PRESIDENT, BIOSPIN GROUP | 48,171 |
| Thierry Bernard | Director | 2,886 |
| Laura Francis | Director | 9,018 |
| Jack Phillips | Director | 4,520 |
| William A. Linton | Director | 63,243 |
| John A. Ornell | Director | 39,732 |
| Richard A. Packer | Director | 93,694 |
| Bob Rosenthal | Director | 38,781 |
| Bonnie H. Anderson | Director | 17,847 |
| Hermann Fritz Requardt | Director | 30,965 |
| Cynthia M. Friend | Director | 22,536 |
| Adelene Q. Perkins | Director | 29,144 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $4.71M | $3.50M | $1.76M | $88 | $68 |
| FY2024 | $5.53M | $3.20M | $2.08M | $110 | $70 |
| FY2023 | $5.86M | $6.27M | $2.01M | $137 | $75 |
| FY2022 | $5.06M | $1.86M | $1.71M | $127 | $84 |
| FY2021 | $5.59M | $14.30M | $1.97M | $155 | $126 |
| FY2020 | $4.08M | $5.09M | $1.46M | $107 | $135 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|---|
| Frank H. Laukien, Ph.D. Chairman, President and Chief Executive Officer | $976.55K | – | $1.62M | $1.49M | $587.27K | $31.05K | $4.71M | -15% |
| Gerald N. Herman Executive Vice President and Chief Financial Officer | $644.23K | – | $866.29K | $264.71K | $215.70K | $19.38K | $2.01M | -12% |
| Falko Busse, Ph.D. President, Bruker BioSpin Group | $544.63K | $3.61K | $311.13K | $104.66K | $136.47K | $320.29K | $1.42M | -24% |
| Mark R. Munch, Ph.D. Executive Vice President & President, Bruker NANO Group | $738.37K | $200.00K | $792.11K | $266.44K | $152.98K | $28.15K | $2.18M | -18% |
| Juergen W. Srega President, Bruker CALID Group | $503.80K | – | $487.50K | $162.50K | $174.78K | $94.01K | $1.42M | -7% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025, Bruker had approximately 11,085 employees worldwide.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?